Teligent Inc (TLGT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.1735 -0.0279 (-13.85%) 10/15/21 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.1735 unch (unch) -
for Fri, Oct 15th, 2021
Results
download Want to compare other data? Select FieldsSymbol | TLGT | ASMB | CPHI | ||
Company | Teligent Inc | Assembly Biosciences | China Pharma Holdings | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
Open | 0.2070 | 11.01 | 1.9400 | ||
High | 0.2090 | 11.04 | 2.0400 | ||
Low | 0.1650 | 11.01 | 1.9400 | ||
Last | 0.1735 | 11.04 | 2.0000 | ||
Change | -0.0279 | +0.22 | +0.0400 | ||
% Change | -13.85% | +2.07% | +2.04% | ||
Volume | 73,687,200 | 2,170 | 7,891 | ||
20-Day Average Volume | 14,124,449 | 26,383 | 131,678 | ||
Previous Close | 0.2014 | 10.82 | 1.9600 | ||
Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
Has Options | No | No | No | ||
Technicals | |||||
20-Day Moving Average | 0.3321 | 9.67 | 1.7237 | ||
20-Day Raw Stochastic | 3.24% | 100.00% | 53.33% | ||
20-Day Relative Strength | 25.55% | 53.50% | 50.87% | ||
Weighted Alpha | -70.26 | -25.89 | -19.21 | ||
Today's Opinion | 100% Sell | 56% Sell | 72% Sell | ||
Previous Opinion | 100% Sell | 80% Sell | 72% Sell | ||
Last Month's Opinion | 100% Sell | 100% Sell | 88% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -44.64% since 10/08/21 | +9.33% since 04/22/25 | +22.70% since 04/22/25 | ||
Low | 0.1650 on 10/15/21 | 10.27 on 04/23/25 | 1.5097 on 04/23/25 | ||
High | 0.3388 on 10/13/21 | 11.01 on 04/29/25 | 2.2200 on 04/25/25 | ||
1-Month | |||||
%Chg | -55.68% since 09/15/21 | +3.67% since 03/28/25 | -27.19% since 03/28/25 | ||
Low | 0.1650 on 10/15/21 | 7.75 on 04/07/25 | 1.2000 on 04/07/25 | ||
High | 0.4275 on 09/30/21 | 11.01 on 04/29/25 | 2.8690 on 03/31/25 | ||
3-Month | |||||
%Chg | -65.30% since 07/15/21 | -20.56% since 01/29/25 | -12.66% since 01/29/25 | ||
Low | 0.1650 on 10/15/21 | 7.75 on 04/07/25 | 1.2000 on 04/07/25 | ||
High | 0.6300 on 08/04/21 | 14.67 on 01/30/25 | 3.1800 on 03/19/25 | ||
6-Month | |||||
%Chg | -69.35% since 04/15/21 | -37.83% since 10/29/24 | -21.69% since 10/29/24 | ||
Low | 0.1650 on 10/15/21 | 7.75 on 04/07/25 | 1.2000 on 04/07/25 | ||
High | 0.6579 on 06/14/21 | 18.05 on 01/03/25 | 3.3500 on 01/07/25 | ||
Key Statistics | |||||
Market Capitalization, $K | 16,104 | 82,639 | 6,393 | ||
Shares Outstanding, K | 92,817 | 7,638 | 3,262 | ||
Annual Sales | 45,310,000 | 28,520,000 | 4,530,000 | ||
Annual Net Income | -122,020,000 | -40,180,000 | -4,740,000 | ||
Last Quarter Sales | 10,430,000 | 7,360,000 | 1,130,000 | ||
Last Quarter Net Income | -12,870,000 | -10,340,000 | -1,220,000 | ||
60-Month Beta | 1.61 | 0.65 | 0.77 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A on 08/16/21 | -1.57 on 03/20/25 | -0.06 on 11/13/24 | ||
Latest Earnings Date | 10/03/22 | 05/14/25 | 05/21/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |